Onivyde Approved for Advanced Pancreatic Cancer

FRIDAY, Oct. 23, 2015 — The injected drug Onivyde (irinotecan liposome) has been approved by the U.S. Food and Drug Administration for pancreatic cancer that has either spread or is surgically untreatable.
Pancreatic cancer is difficult to treat,…
Source: Topamax